產(chǎn)品詳情
簡(jiǎn)單介紹：
Anti-phospho-CRK (Tyr221)抗體產(chǎn)品質(zhì)量穩(wěn)定，實(shí)驗(yàn)效果明顯，貨期快，價(jià)格優(yōu)惠，歡迎垂詢訂購(gòu)！我公司長(zhǎng)期供應(yīng)**組化抗體、WB抗體、**組化試劑盒和抗體試驗(yàn)所需全部相關(guān)試劑、熒光標(biāo)記抗體、單克隆抗體、多克隆抗體、各種標(biāo)記的二抗IgG/IgM/IgD/IgA等科研實(shí)驗(yàn)抗體。Anti-phospho-CRK (Tyr221)抗體用于**組化實(shí)驗(yàn),WB實(shí)驗(yàn),相應(yīng)的標(biāo)記抗體有HRP標(biāo)記抗體,FITC標(biāo)記,BIO等。
詳情介紹：
Rabbit Anti-phospho-CRK (Tyr221)
Cat. Number:
Anti-phospho-CRK (Tyr221)抗體KL-3121R
Quantity size:
0.1ml
Concentration:
1mg/ml Buffer = 0.01M TBS(pH7.4) with 1% BSA, 0.03% Proclin300 and 50% Glycerol.
Background:
Crk p38 (CrkII) is an isoform of the protein Crk. CrkI and CrkII are produced from the same crk gene by alternative splicing. Anti-phospho-CRK (Tyr221)抗體The two isoforms differ in their biological activities with CrkII having less transforming activity than CrkI. Crk p38 is a member of an adapter protein family that binds to several tyrosine-phosphorylated proteins. It has several SH2 and SH3 domains (src-homology domains) and is involved in several signaling pathways, recruiting cytoplasmic proteins in the vicinity of tyrosine kinase through SH2-phosphotyrosine interaction. The N-terminal SH2 domain of this protein functions as a positive regulator of transformation whereas the C-terminal SH3 domain functions as a negative regulator of transformation. Crk is believed to be a regulator of invasive responses because increased levels of the protein have been observed in multiple human cancers. In vivo studies have demonstrated that decreased levels of Crk remarkably inhibits tumor formation and its Anti-phospho-CRK (Tyr221)抗體invasive growth.
Also known as:
Crk p38 (phospho Y221); p-Crk p38 (phospho Y221); p-CRK(phospho-Tyr221); p-CRK(phospho-Y221); Crk p38; CRK CRK isoform 2; CRK isoform II; CRKII; p38; Proto oncogene C crk; v crk avian sarcoma virus CT10 oncogeneAnti-phospho-CRK (Tyr221)抗體 homolog ; v crk sarcoma virus CT10 oncogene homolog; v crk sarcoma virus CT10 oncogene homolog (avian); Adapter molecule crk; Avian sarcoma virus CT10 (v crk) oncogene homolog; CRK_HUMAN
Specificity:
●
Rabbit Polyclonal IgG, affinity purified by Protein A.
●
Reacts with: Human, Mouse, Rat, Chicken, Dog, Horse, Rabbit, .
●
Immunogen: KLH conjugated Synthesised phosphopeptide derived from human Crk p38 around the phosphorylation site of Tyr221 [GP(p-Y)AQ].
●
Predicted Molecular Weight: 38kDa.
Storage:
Shipped at 4℃, Store Anti-phospho-CRK (Tyr221)抗體at -20℃ (Avoid repeated freeze/thaw cycles).
Application:
WB=1:100-500 ELISA=1:500-1000 IHC-P=1:100-500 IHC-F=1:100-500 IF=1:100-500
Not yet tested in other applications.
Optimal working dilutions must be determined by the end user.
Not yet tested in other applications.
Optimal working dilutions must be determined by the end user.
kl124Ra01 轉(zhuǎn)化生長(zhǎng)因子β1(TGFβ1)多克隆抗體 Polyclonal Antibody to Transforming Growth Factor Beta 1 (TGFb1)
kl124Gu01 轉(zhuǎn)化生長(zhǎng)因子β1(TGFβ1)多克隆抗體 Polyclonal Antibody to Transforming Growth Factor Beta 1 (TGFb1)
kl124Rb51 轉(zhuǎn)化生長(zhǎng)因子β1(TGFβ1)多克隆抗體 Polyclonal Antibody to Transforming Growth Factor Beta 1 (TGFb1)
kl124Ca01 轉(zhuǎn)化生長(zhǎng)因子β1(TGFβ1)多克隆抗體 Polyclonal Antibody to Transforming Growth Factor Beta 1 (TGFb1)
kl124Bo01 轉(zhuǎn)化生長(zhǎng)因子β1(TGFβ1)多克隆抗體 Polyclonal Antibody to Transforming Growth Factor Beta 1 (TGFb1)
kl124Po01 轉(zhuǎn)化生長(zhǎng)因子β1(TGFβ1)多克隆抗體 Polyclonal Antibody to Transforming Growth Factor Beta 1 (TGFb1)
kl124Cp01 轉(zhuǎn)化生長(zhǎng)因子β1(TGFβ1)多克隆抗體 Polyclonal Antibody to Transforming Growth Factor Beta 1 (TGFb1)
kl124Eq01 轉(zhuǎn)化生長(zhǎng)因子β1(TGFβ1)多克隆抗體 Polyclonal Antibody to Transforming Growth Factor Beta 1 (TGFb1)
kl124Ga01 轉(zhuǎn)化生長(zhǎng)因子β1(TGFβ1)多克隆抗體 Polyclonal Antibody to Transforming Growth Factor Beta 1 (TGFb1)
kl765Hu01 精氨酸加壓素誘導(dǎo)蛋白1(AVPI1)多克隆抗體 Polyclonal Antibody to Arginine Vasopressin Induced Protein 1 (AVPI1)
kl765Mu01 精氨酸加壓素誘導(dǎo)蛋白1(AVPI1)多克隆抗體 Polyclonal Antibody to Arginine Vasopressin Induced Protein 1 (AVPI1)
